Literature DB >> 19039204

Human osteoblasts support hematopoietic cell development in vitro.

Yusuke Shiozawa1, Hisami Takenouchi, Tomoko Taguchi, Masahiro Saito, Yohko U Katagiri, Hajime Okita, Toshiaki Shimizu, Yuichiro Yamashiro, Junichiro Fujimoto, Nobutaka Kiyokawa.   

Abstract

BACKGROUND/AIM: Although osteoblasts are thought to be the major component of the hematopoietic stem cell niche in the bone marrow microenvironment, the role of osteoblasts in hematopoiesis is still unclear. The ability of human osteoblasts to support early hematopoiesis was investigated. METHODS AND
RESULTS: Human CD34+ bone marrow cells cultured on human osteoblasts were capable of surviving without addition of cytokines and differentiated into myeloid cells with slight proliferation. The results of immunohistochemical experiments suggested activation of FAK and AKT in hematopoietic cells attached to osteoblasts. When stem cell factor, Flt3-L, and IL-3 were added to the coculture system, each cytokine distinctively enhanced proliferation and differentiation of CD34+ bone marrow cells.
CONCLUSION: The results suggest that human osteoblasts have the ability to support hematopoietic cell development in vitro. Copyright 2008 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19039204     DOI: 10.1159/000178144

Source DB:  PubMed          Journal:  Acta Haematol        ISSN: 0001-5792            Impact factor:   2.195


  4 in total

1.  Comparable osteogenic capacity of mesenchymal stem or stromal cells derived from human amnion membrane and bone marrow.

Authors:  Mehran Ghasemzadeh; Ehteramolsadat Hosseini; Mohammadhossein Ahmadi; Maedeh Kamalizad; Naser Amirizadeh
Journal:  Cytotechnology       Date:  2018-01-05       Impact factor: 2.058

Review 2.  Niche-directed therapy in acute myeloid leukemia: optimization of stem cell competition for niche occupancy.

Authors:  Shyam A Patel; Disha Dalela; Amy C Fan; Maxwell R Lloyd; Tian Y Zhang
Journal:  Leuk Lymphoma       Date:  2021-08-19

3.  Impact of maturational status on the ability of osteoblasts to enhance the hematopoietic function of stem and progenitor cells.

Authors:  Ying-Hua Cheng; Brahmananda R Chitteti; Drew A Streicher; Joseph A Morgan; Sonia Rodriguez-Rodriguez; Nadia Carlesso; Edward F Srour; Melissa A Kacena
Journal:  J Bone Miner Res       Date:  2011-05       Impact factor: 6.741

4.  Osteoblast Derived Exosomes Alleviate Radiation- Induced Hematopoietic Injury.

Authors:  Jianqi Xue; Ruikai Du; Shukuan Ling; Jinping Song; Xinxin Yuan; Caizhi Liu; Weijia Sun; Yuheng Li; Guohui Zhong; Yinbo Wang; Guodong Yuan; Xiaoyan Jin; Zizhong Liu; Dingsheng Zhao; Youyou Li; Wenjuan Xing; Yuanyuan Fan; Zifan Liu; Junjie Pan; Zhen Zhen; Yunzhang Zhao; Qinna Yang; Jianwei Li; Yan-Zhong Chang; Yingxian Li
Journal:  Front Bioeng Biotechnol       Date:  2022-04-21
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.